-
公开(公告)号:US11945880B2
公开(公告)日:2024-04-02
申请号:US17542342
申请日:2021-12-03
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , C07K16/2809 , C07K16/2866 , C07K16/2887 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K16/40 , A61K2039/505 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/70 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US11312770B2
公开(公告)日:2022-04-26
申请号:US16184895
申请日:2018-11-08
Applicant: Xencor, Inc.
Inventor: Matthew Bernett , Gregory Moore , John Desjarlais , Michael Hedvat , Christine Bonzon , Alex Nisthal , Umesh Muchhal
IPC: C07K16/28 , A61P35/00 , C07K16/46 , A61K39/395 , A61K39/00
Abstract: The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
-
公开(公告)号:US20210102003A1
公开(公告)日:2021-04-08
申请号:US17124371
申请日:2020-12-16
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US10889653B2
公开(公告)日:2021-01-12
申请号:US14952714
申请日:2015-11-25
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US10526417B2
公开(公告)日:2020-01-07
申请号:US14952786
申请日:2015-11-25
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
-
公开(公告)号:US20160355608A1
公开(公告)日:2016-12-08
申请号:US15141350
申请日:2016-04-28
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2866 , C07K16/2887 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K16/40 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/70 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US20160215063A1
公开(公告)日:2016-07-28
申请号:US14952786
申请日:2015-11-25
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Abstract translation: 本发明涉及结合CD3和CD38的异二聚体抗体。
-
公开(公告)号:US20230365717A1
公开(公告)日:2023-11-16
申请号:US18308623
申请日:2023-04-27
Applicant: Xencor, Inc.
Inventor: Matthew Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , C07K16/2809 , C07K16/2896 , C07K16/30 , C07K16/2818 , C07K16/3061 , A61K2039/505
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US20220162343A1
公开(公告)日:2022-05-26
申请号:US17542342
申请日:2021-12-03
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US10259887B2
公开(公告)日:2019-04-16
申请号:US15141350
申请日:2016-04-28
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
-
-
-
-
-
-
-
-